These results, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two guidance the concept of targeting ACKR3 as a novel way to modulate the opioid system, which could open up new therapeutic avenues for opioid-connected Issues.